A comprehensive surveillance of adamantane resistance among human influenza A virus isolated from mainland China between 1956 and 2009

Antiviral Therapy

Volumn 15, Issue 6, 2010, Pages 853-859

  Lan, Yu ^a   Zhang, Ye ^a   Dong, Libo ^a   Wang, Dayan ^a   Huang, Weijuan ^a   Xin, Li ^a   Yang, Limei ^a   Zhao, Xiang ^a   Li, Zi ^a   Wang, Wei ^a   Li, Xiyan ^a   Xu, Cuilin ^a   Yang, Lei ^a   Guo, Junfeng ^a   Wang, Min ^a   Peng, Yousong ^b   Gao, Yan ^a   Guo, Yuanji ^a   Wen, Leying ^a   Jiang, Taijiao ^b   Shu, Yuelong ^a   more..

^a NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; AMANTADINE; RIMANTADINE; VIRUS RNA;

ARTICLE; CHINA; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; GENETIC REASSORTMENT; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS ISOLATION;

ADAMANTANE; ANTIVIRAL AGENTS; CHINA; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; PHYLOGENY; RIMANTADINE; RNA, VIRAL; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE ANALYSIS, RNA; VIRAL MATRIX PROTEINS;

EID: 77957351769     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1656     Document Type: Article

References (29)

1. Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007; 196:249-257.
2. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232-239.
3. Tominack RL, Hayden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am 1987; 1:459-478.
4. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307:580-584.
5. Tsiodras S, Mooney JD, Hatzakis A. Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ 2007; 334:293-294.
6. Wang C, Takeuchi K, Pinto LH, Lamb RA. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol 1993; 67:5585-5594.
7. Suzuki H, Saito R, Masuda H, Oshitani H, Sato M, Sato I. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother 2003; 9:195-200.
8. Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol 1988; 62:1508-1512.
9. Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH. Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother 1986; 18 Suppl B:19-29.
10. Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366:1175-1181.
11. Saito R, Suzuki Y, Li D, et al. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J Infect Dis 2008; 197:630-632. Author reply 632-633.
12. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006; 295:891-894.
13. World Health Organization. Cumulative number of confirmed cases of avian influenza A/(H5N1) reported to WHO. (Updated 30 December 2009. Accessed 30 December 2009.) Available from http://www.who.int/csr/disease/avian-influenza/ country/cases-table-2009-12-30/en/index.html
14. Yu H, Shu Y, Hu S, et al. The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet 2006; 367:84.
15. Shu Y, Yu H, Li D. Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China. N Engl J Med 2006; 354:1421-1422.
16. Zhu QY, Qin ED, Wang W, et al. Fatal infection with influenza A (H5N1) virus in China. N Engl J Med 2006; 354:2731-2732.
17. Cheung CL, Rayner JM, Smith GJ, et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 2006; 193:1626-1629.
18. He G, Qiao J, Dong C, He C, Zhao L, Tian Y. Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antiviral Res 2008; 77:72-76.
19. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37:937-943.
20. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487-491.
21. Felsenstein J. Mathematics vs. evolution: mathematical evolutionary theory. Science 1989; 246:941-942.
22. Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 2009; 47:841-844.
23. Furuse Y, Suzuki A, Kishi M, et al. Occurrence of mixed populations of influenza A viruses that can be maintained through transmission in a single host and potential for reassortmant. J Clin Microbiol 2009; 48:369-374.
24. Nelson MI, Viboud C, Simonsen L, et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 2008; 4:e1000012.
25. Furuse Y, Suzuki A, Kamigaki T, Oshitani H. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J 2009; 6:67.
26. Barr IG, Deng YM, Iannello P, Hurt AC, Komadina N. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antiviral Res 2008; 80:200-205.
27. Centers for Disease Control and Prevention. 2009-2010 Influenza season week 51 ending December 26, 2009. (Updated 31 December 2009. Accessed 26 December 2009.) Available from http://www.cdc.gov/flu/weekly/weeklyarchives2009- 2010/weekly51.htm
28. World Health Organization Europe. WHO/Europe influenza surveillance (EuroFlu.org). (Updated 8 January 2010. Accessed 28 December 2009.) Available from http://www.euroflu.org/index.php
29. Australian Government Department of Health and Ageing. Australian influenza surveillance summary report, 5 December 2009-11 December 2009. (Updated 11 December 2009. Accessed 11 December 2009.) Available from http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/ Content/18D06BAC4644C98DCA25763E00823442/$File/ozflu-no31-2009.pdf